Kritz H, Zielinski C, Sinzinger H
Department of Nuclear Medicine, University of Vienna, Austria.
J Clin Oncol. 1996 Nov;14(11):3043-8. doi: 10.1200/JCO.1996.14.11.3043.
The relation between plasma cholesterol (CH) concentration and mortality is complex. The plasma CH concentration correlates positively with mortality from coronary heart disease, but some studies have shown a negative relation with death from cancer. If these two relations reflect causal mechanisms that are reversible by changing the plasma CH concentration, the benefits of lipid reduction for heart disease might be offset by an increased mortality from cancer. Different aspects between lipid metabolism and cancer, as well as new insights into this interesting field, are discussed.
The literature was searched using MedLine through 1966 and January 1996.
There is no evidence from the data available at present that the association between low CH and a higher risk of cancer is causal.
This issue should not affect the advice on health matters offered by doctors, especially to patients with other risk factors for cardiovascular disease. The possibility that hypercholesterolemia (HC) drugs can induce a reduction of tumor-cell growth makes them potentially useful as an adjuvant to chemotherapy and ultimately increases the probabilities in the prevention and treatment of cancer.
血浆胆固醇(CH)浓度与死亡率之间的关系很复杂。血浆CH浓度与冠心病死亡率呈正相关,但一些研究表明与癌症死亡率呈负相关。如果这两种关系反映了可通过改变血浆CH浓度而逆转的因果机制,那么降低血脂对心脏病的益处可能会被癌症死亡率的增加所抵消。本文讨论了脂质代谢与癌症之间的不同方面,以及对这个有趣领域的新见解。
通过MedLine检索了1966年至1996年1月的文献。
目前可得的数据中没有证据表明低CH与较高癌症风险之间的关联是因果关系。
这个问题不应影响医生提供的健康建议,尤其是对有其他心血管疾病风险因素的患者。高胆固醇血症(HC)药物可诱导肿瘤细胞生长减少,这使其有可能作为化疗辅助药物,最终增加癌症预防和治疗的可能性。